Estrogenic substances combined with cruciferous indole compounds
OwnerMilton Hammerlyinventor
Life of this patent
Estimating the term…
Abstract
Provided herein are medicinal compositions of matter that comprise an estrogenic medication component and a cruciferous indole component (indole 3-carbinol, diindolylmethane, or any derivative thereof. Through use of the compositions of the invention a heretofore unobserved synergy is observed in the treatment of perimenopause, menopause or any other cause of ovarian failure. The invention also provides procedures for administering the composition to a patient who is afflicted with perimenopause, menopause or any other cause of ovarian failure.
Claims34
A medicinal composition useful in estrogen replacement therapy comprising:
- a) an estrogenic substance;
- and
- b) a cruciferous indole compound component.
A medicinal composition useful in the treatment of estrogen replacement therapy comprising an estrogenic substance selected from the group consisting of:
- estrogen;
- conjugated estrogens;
- dienestrol;
- estrone;
- esterified estrogens;
- estradiol;
- estriol;
- and estropipate;
- ethinyl estradiol;
- or any estrogenic derivative of the foregoing;
- and further comprising indole 3-carbinol.
A medicinal composition useful in the treatment of estrogen replacement therapy comprising an estrogenic substance selected from the group consisting of:
- estrogen;
- conjugated estrogens;
- dienestrol;
- estrone;
- esterified estrogens;
- estradiol;
- estriol;
- and estropipate;
- ethinyl estradiol;
- or any estrogenic derivative of the foregoing;
- and further comprising diindolylmethane.
A method of providing estrogen replacement therapy to a patient needing same, the method comprising:
- administration of a therapeutically-effective amount of a estrogenic substance in synergistic combination with a therapeutically effective amount of a cruciferous indole compound selected from the group consisting of:
- indole 3-carbinol;
- and diindolylmethane, and derivatives thereof,
- wherein the estrogenic substance is administered to alleviate symptoms of estrogen deficiency, and the cruciferous indole compound is administered to increase 2-hydroxyestrogen metabolites and to decrease 16-hydroxyestrogen metabolites in said patient.
A process in estrogen replacement therapy comprising the steps of:
- a) providing a combination comprising:
- i) an estrogenic substance component;
- and
- ii) a cruciferous indole compound component, and
- b) introducing said composition into a human body that is afflicted with an deficiency of an estrogenic substance.
Dependencies are inferred from the claim text.